ALQGC — Quantum Genomics SA Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study
Brief: Quantum Genomics End-June Available Cash At EUR 19.5 Mln
Brief: Quantum Genomics To Present Results From Phase III FRESH Study On Hypertension On Nov 4
Brief: Quantum Genomics Announces End Of Patient Recruitment For Phase III Pivotal Study FRESH
Brief: Quantum Genomics FY Operating Loss Widens To 19.2 Million Euros
Brief: Julphar Enters Into A Subscription Agreement With Quantum Genomics
Brief: Quantum Genomics Raises About 15 Mln Euros Gross In Capital Increase
Brief: Quantum Genomics Announces Publication Of New Scientific Article Featuring QGC606
Brief: Quantum Genomics Announces Granting Of New Patents Protecting Qgc606
Brief: Quantum Genomics Announces Granting Of New Patents Protecting QGC606
Brief: Quantum Genomics Signs Exclusive License And Production Deal With Julphar
Brief: Julphar Signs An Exclusive License And Production Agreement With Quantum Genomics
Brief: Quantum Genomics Signs Exclusive License Agreement With Teva Israel
Brief: Quantum Genomics Eyes Firibastat's Market Debut At End Of 2023
Brief: Quantum Genomics H1 Operating Loss Widens To Eur 7.2 Mln
Brief: Quantum Genomics: Results Of Phase IIb Study Of Its Firibastat Drug